Michael P Kane, Pharm.D., FCCP, BCPS, BCACP

Bio: 

Education

  • Pharm.D., Medical University of South Carolina 
  • Clinical Pharmacy Resident, Adult Internal Medicine, Medical University Hospital Medical University of South Carolina, Charleston, SC
  • Hospital Pharmacy Resident, Greenwich Hospital Association Greenwich, CT 
  • B.S., Albany College of Pharmacy and Health Sciences

Courses Taught at ACPHS

  • Integrated Problem Solving Workshop 5 (Facilitator)
  • Integrated Problem Solving Workshop 4 (Facilitator)
  • PTPM Endocrinology
  • APPE - Ambulatory Care Endocrinology/Internal Medicine rotation

Research Interests

  • Assessing the safety and efficacy of new drugs in the management of diabetes mellitus and osteoporosis.

Selected Publications

Jonklaas J, Kane MP. Thyroid disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach, 10th edition. New York, NY: McGraw-Hill Education, 2016. In press.

 Saroka RM, Kane MP, Robinson L, Busch RS. No postoperative adrenal insufficiency in a patient with unilateral cortisol-secreting adenomas treated with mifepristone before surgery. Clinical Med Insights: Endocrinology and Diabetes. 2016;9:1-6.

 Kane MP, Hamilton RA. Determination of the glycemic index of a diabetes truffle. Journal of Global Diabetes and Clinical Metabolism. 2016;1:22-4. 

 Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2016 ed. Lenexa, KS: American College of Clinical Pharmacy, 2016:1:679-1740.

 Brady SM, Kane MP, Busch RS. GLP-1 Agonist Use in a Patient with an Explainable Cause of Pancreatitis. AACE Clinical Case Reports. Spring, 2016. DOI 10.4158/EP15658.CR  

 Saroka RM, Kane MP, Busch RS, Watsky J, Hamilton RA. SGLT-2 inhibitor therapy added to GLP-1 agonist therapy in the management of T2DM. Endocrine Practice. 2015;21(12):1315-22.

 Kane MP. Hyperthyroidism: Graves’ Disease. In: Katz M, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach, 4th Edition. McGraw Hill: New York, NY, 2015.

Kane MP. Endocrine Disorders. In: Bainbridge JL, Branham, A, Coyle EA, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy, 2015:1-39- 1-96.

Nardolillo A, Kane MP, Busch RS, Watsky J, Hamilton RA. A clinical perspective of canagliflozin in the management of type 2 diabetes mellitus. Clinical Medicine Insights: Endocrinology and Diabetes. 2014;7:25-30. 

Micale SJ, Khatounabadi S, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Weekly-Exenatide Therapy: A Real-World Comparison of Incretin Therapies; Journal of Pharmacy Technology August 2014;30:118-24.

Kane MP. Diabetes Mellitus. In: Bainbridge JL, Barbour SY, Coyle EA, et al. ACCP Updates in Therapeutics 2014: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2014 ed. Lenexa, KS. American College of Clinical Pharmacy, 2014:1-33. 

Kane MP. Endocrine Disorders. In: Bainbridge JL, Barbour SY, Coyle EA, et al. ACCP Updates in Therapeutics 2014: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2014 ed. Lenexa, KS. American College of Clinical Pharmacy, 2014:39–92.

Selected Poster/Platform Presentations

Diabetes Update. Presented at the NY American Society of Consulting Pharmacists Mid-State Chapter Meeting and Education Day, June 16, 2016, Genesee Grand Hotel, Syracuse, NY. 

 Keynote Address: The Capital District Residency & Fellowship Graduation Luncheon. June 8, 2016, Hilton Garden Inn, Albany, NY. 

 Stryker M, Kane MP, Busch RS, Hamilton RA. A pharmacist-run proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor clinic: short-term results and practical strategies. Presented at the ACCP Virtual Poster Symposium, May 18, 2016. 

 Stryker M, Kane MP, Busch RS, Hamilton RA.An Evaluation Of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients With Diabetes Mellitus. Presented at the National Lipid Association Annual Meeting, May 18, 2016, New Orleans, LA. 

 Strategies for Diabetes Prevention. Presented at the Mid-Hudson Regional Hospital Pre-diabetes Epidemic Conference; Public Health Impact & Prevention of Type 2 Diabetes. Presented May 14, 2016, Sister M. Ann Elizabeth Conference Center, Poughkeepsie, NY.  

 ACCP 2016 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Endocrine Disorders. Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 9, 2016, Phoenix, AZ.

 The New Classes of Diabetes Medications: A Synopsis. Presented for Grand Rounds at the Baystate Medical Center, Springfield, MA, March 22, 2016. 

 Obesity Is a Chronic Disease: Let’s Treat it That Way. Presented at the 2016 APhA Annual Meeting, Baltimore, MD, March 7, 2016. 

 Stryker M, Kane MP, Busch RS, Hamilton RA. Poster #388595: Evaluating the off-label use of once-weekly exenatide in combination with basal insulin therapy in patients with type 2 diabetes mellitus. 2015 ASHP Midyear Clinical Meeting, New Orleans, Louisiana, December 9, 2015.

 Diabetes Update. Presented to the Central New York Chapter of the New York State Council of Health-system Pharmacists, Syracuse, NY, November 18, 2015. 

 Effective Strategies to Reduce Adverse Drug Events: Prevention of Hypoglycemia in the Elderly. Presented at the New York State Chapter of the American College of Clinical Pharmacy (NYS-ACCP) 2015 Fall Clinical Meeting, Albany, NY, November 13, 2015.

 Diabetes Medications – Guidelines for use in the Older Adult. Presented at the Upstate New York American Diabetes Association 2015 Diabetes Summit, Diabetes and the Older Adult. Scotia, NY. November 4, 2015.

 GLP-1 Agonists, SGLT-2 inhibitors and New Insulins: An Update in the Management of Diabetes. Presented to the Vermont Pharmacists Association, May 31, 2015, Montpelier, VT.

 ACCP 2015 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented  April 10, 2015, Rosemont, IL.

Saroka R, Kane MP, Busch RS, Watsky J, Hamilton RA. A six-month clinical perspective of canagliflozin added to GLP-1 therapy in the management of T2DM. Poster presented at the 2014 ASHP Midyear Clinical Meeting, December 10, 2014, Anaheim, CA.

Updates in Managing T2DM. Presented at Internal Medicine/Endocrinology Grand Rounds at Hartford Hospital, November 6, 2014, Hartford, CT.

Clinical Controversies, Fast and Furious - Male Testosterone Deficiency: Should it be treated? Presented at the American College of Clinical Pharmacy (ACCP) Annual Meeting, October 13, 2014, Austin, TX.

ACCP 2014 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Diabetes Mellitus. Presented the Diabetes section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 11,   2014, Rosemont, IL.

ACCP 2014 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented the Other Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 11, 2014, Rosemont, IL.

The Pharmacotherapy of Prediabetes. Grand Rounds, presented to pharmacists, physicians, nurse practitioners and physician assistants at The Endocrine Group; January 8, 2014, Albany, NY.

Research Grants

A Real World, Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus. Kane MP, Stryker M, Busch SA, Hamilton RA. Albany College of Pharmacy and Health Sciences and Albany Medical Center Division of Community Endocrinology (The Endocrine Group). Awarded $67,387; AstraZeneca Pharmaceuticals, LP; 6/16.

Determination of the Glycemic Index of Raw Amour Diabetes Truffle. Kane MP, Hamilton RA. Albany College of Pharmacy and Health Sciences. Awarded $1900; Raw Amour, 12/15.

Honors and Appointments

  • Recipient of the 2010 American College of Clinical Pharmacy, Clinical Practice Award; presented October 14, 2010, Austin, TX
  • Appointed to Board of Trustees of Northeast Kidney Foundation in 2015

Clinical Affiliations

  • Clinical Pharmacy Specialist – Albany Medical Center Division of Community Endocrinology (The Endocrine Group), Albany, NY
  • Preceptor – Residency in Adult Internal Medicine/Endocrinology
  • Fellow of the American College of Clinical Pharmacy
  • Board Certified in Pharmacotherapy (since 1991)
  • Board Certified in Ambulatory Care Pharmacy (since 2011)
Professor
Department of Pharmacy Practice